Engineered bacteria: a novel era for metabolic, cardiovascular and cerebrovascular diseases therapy.
- 2026-03-10
- Review
- Frontiers in cardiovascular medicine 13
- Yuzhe Wu
- Ruiqi Sang
- Xiangnan Chen
- Songyun Wang
- PubMed: 41884636
- DOI: 10.3389/fcvm.2026.1757348
- Low evidence
consumption of Lactobacillus gasseri LG-36 ... may improve the gut microbiota composition
- Effect
- Beneficial
- Effect size
- Small